The Effect Profitability Ratio On Pharmaceutical Company Listed On The Indonesia Stock Exchange Period 2017-2022

SABRINA, RAZITA NUR (2024) The Effect Profitability Ratio On Pharmaceutical Company Listed On The Indonesia Stock Exchange Period 2017-2022. Other thesis, UPT PERPUSTAKAAN POLSRI.

	Text 1. COVER DEPAN - DAFTAR TABEL.pdf Download (848kB)
	Text 2. BAB I PENDAHULUAN.pdf Download (204kB)
	Text 3. BAB II TINJAUAN PUSTAKA.pdf Download (35kB)
	Text 4. BAB III METODOLOGI PENELITIAN.pdf Restricted to Repository staff only Download (309kB) | Request a copy
	Text 5. BAB IV HASIL DAN PEMBAHASAN.pdf Restricted to Repository staff only Download (355kB) | Request a copy
Preview	Text 6. BAB V SIMPULAN DAN SARAN.pdf Download (36kB) | Preview
Preview	Text 7. DAFTAR PUSTAKA.pdf Download (127kB) | Preview
Preview	Text 8. LAMPIRAN.pdf Download (295kB) | Preview

Abstract

This study investigates how Return on Assets (ROA), Return on Equity (ROE), and Price Earnings Ratio (PER) influence the stock prices of pharmaceutical companies on the Indonesia Stock Exchange (IDX) between 2017 and 2022. Analyzing ROA during this period provides insights into the operational leverage of these companies and its correlation with stock price fluctuations. ROE assesses how efficiently a company uses its equity capital to generate profits, offering a view of its profitability relative to shareholder equity. Variations in ROE may affect investors' sentiments and influence stock prices, demonstrating the relationship between ROE and stock prices within the given timeframe. PER compares a company's stock price to its earnings per share, making it a significant valuation metric. A high Price Earnings Ratio typically indicates that investors expect future earnings to increase. Tracking the PER of pharmaceutical companies on the IDX from 2017 to 2022 helps understand investor perceptions and anticipations, with PER fluctuations signaling shifts in market sentiment and impacting stock valuations. This study employs a multiple linear regression method to analyze financial statements, market information, and stock prices of nine pharmaceutical firms listed on the IDX between 2017 and 2022. Classical assumption tests, including normality, multicollinearity, and autocorrelation tests, were conducted to ensure the reliability of the regression analysis. Data analysis was performed using Microsoft Excel and SPSS.

Item Type:	Thesis (Other)
Uncontrolled Keywords:	Return on Assets (ROA), Return on Equity (ROE), Price Earnings Ratio (PER), Stock Exchange(IDX), pharmaceutical sector.
Subjects:	H Social Sciences > H Social Sciences (General) H Social Sciences > HB Economic Theory
Divisions:	Accounting > Undergraduate Theses
Depositing User:	Mr Bambang Anthony
Date Deposited:	05 Mar 2025 04:44
Last Modified:	05 Mar 2025 04:44
URI:	http://eprints.polsri.ac.id/id/eprint/16243

Actions (login required)

View Item